Lipella Pharmaceuticals Common Stock Buy Hold or Sell Recommendation
| LIPO Stock | 3.19 0.06 1.92% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Lipella Pharmaceuticals Common is 'Cautious Hold'. The recommendation algorithm takes into account all of Lipella Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
Check out Lipella Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Lipella and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Lipella |
Execute Lipella Pharmaceuticals Buy or Sell Advice
The Lipella recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lipella Pharmaceuticals Common. Macroaxis does not own or have any residual interests in Lipella Pharmaceuticals Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lipella Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Insignificant | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Lipella Pharmaceuticals Trading Alerts and Improvement Suggestions
| Lipella Pharmaceuticals is way too risky over 90 days horizon | |
| Lipella Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 449.62 K. Net Loss for the year was (4.62 M) with loss before overhead, payroll, taxes, and interest of (2.36 M). | |
| Lipella Pharmaceuticals generates negative cash flow from operations | |
| About 29.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Lipella Pharmaceuticals Revises Placement Agent Agreement Terms |
Lipella Pharmaceuticals Returns Distribution Density
The distribution of Lipella Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Lipella Pharmaceuticals' future price movements. The chart of the probability distribution of Lipella Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Lipella Pharmaceuticals Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lipella Pharmaceuticals returns is essential to provide solid investment advice for Lipella Pharmaceuticals.
| Mean Return | 1.08 | Value At Risk | -10.47 | Potential Upside | 12.62 | Standard Deviation | 13.26 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lipella Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lipella Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Lipella Pharmaceuticals, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Lipella Pharmaceuticals Common back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Virtu Financial Llc | 2024-12-31 | 13.3 K | Mccormack Advisors International | 2024-12-31 | 125 | Bank Of America Corp | 2024-12-31 | 7.0 | Sabby Management Llc | 2024-09-30 | 0.0 | Two Sigma Investments Llc | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-09-30 | 0.0 |
Lipella Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lipella Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lipella Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lipella stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.08 | |
β | Beta against Dow Jones | 1.66 | |
σ | Overall volatility | 13.86 | |
Ir | Information ratio | 0.08 |
Lipella Pharmaceuticals Volatility Alert
Lipella Pharmaceuticals Common is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lipella Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lipella Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Lipella Pharmaceuticals Fundamentals Vs Peers
Comparing Lipella Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lipella Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Lipella Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lipella Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lipella Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Lipella Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lipella Pharmaceuticals to competition |
| Fundamentals | Lipella Pharmaceuticals | Peer Average |
| Return On Equity | -1.72 | -0.31 |
| Return On Asset | -0.94 | -0.14 |
| Operating Margin | (6.98) % | (5.51) % |
| Current Valuation | 2.57 M | 16.62 B |
| Shares Outstanding | 1.21 M | 571.82 M |
| Shares Owned By Insiders | 29.37 % | 10.09 % |
| Shares Owned By Institutions | 6.51 % | 39.21 % |
| Number Of Shares Shorted | 30.82 K | 4.71 M |
| Price To Book | 2.59 X | 9.51 X |
| Price To Sales | 7.98 X | 11.42 X |
| Revenue | 449.62 K | 9.43 B |
| Gross Profit | (2.36 M) | 27.38 B |
| EBITDA | (4.61 M) | 3.9 B |
| Net Income | (4.62 M) | 570.98 M |
| Total Debt | 136.59 K | 5.32 B |
| Book Value Per Share | 1.79 X | 1.93 K |
| Cash Flow From Operations | (3.15 M) | 971.22 M |
| Short Ratio | 0.01 X | 4.00 X |
| Earnings Per Share | (4.88) X | 3.12 X |
| Target Price | 16.0 | |
| Number Of Employees | 5 | 18.84 K |
| Market Capitalization | 3.57 M | 19.03 B |
| Total Asset | 3.58 M | 29.47 B |
| Retained Earnings | (10.32 M) | 9.33 B |
| Working Capital | 3.04 M | 1.48 B |
| Net Asset | 3.58 M |
Note: Disposition of 11795 shares by Kaufman Jonathan H of Lipella Pharmaceuticals at 1.0 subject to Rule 16b-3 [view details]
Lipella Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lipella . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Lipella Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Lipella Pharmaceuticals Common? Buying financial instruments such as Lipella Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lipella Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cigarettes Thematic Idea Now
Cigarettes
Tobacco makers and distributors across globe. The Cigarettes theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Lipella Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.88) | Revenue Per Share | Quarterly Revenue Growth 0.279 | Return On Assets | Return On Equity |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.